Home›People›Aaron Ring
AR

Aaron Ring

Associate Professor, Fred Hutch and director at Stipple Bio. Also an executive officer and director at Seranova Bio.

ExecutiveDirectorRoles at 2 startups
Updated Nov 10, 2026·Latest SEC filing Apr 6, 2026·Suggest an edit

About Aaron Ring

Aaron Ring is an associate professor, fred hutch and director at Stipple Bio.

Form D filings also name Aaron Ring as an executive officer and director at Seranova Bio.

Aaron Ring first appears on SEC filings in 2021.

Experience

This experience comes from Aaron Ring's profile and from SEC filings. For roles taken from filings, the years are when the filings name Aaron Ring in the role, so the role may have started earlier or lasted longer.

Ariax Bio Current
Founder
2025 – Present
Fred Hutch Current
Associate Professor
2023 – Present
Stipple Bio, Inc. Current
Associate Professor, Fred Hutch and director
Co-Founder (2022 – Present)
2022 – Present · Cambridge, MA
Develops targeted cancer medicines for people with cancer.
Seranova Bio, Inc. Current
Founder (2021 – Present)
Director
2021 – Present · South San Francisco, CA
Simcha Therapeutics Current
Founder
2018 – Present
Yale University School of Medicine
Associate Professor of Immunobiology (2022 – 2023)
Beckman Scholar (2005 – 2008)
2005 – 2023
Yale School of Medicine
Assistant Professor of Immunobiology
2016 – 2022
Stanford University School of Medicine
MD/PhD Candidate
2008 – 2016

Key Colleagues at Startups

The people Aaron Ring works with at each company, as listed on that company's latest Form D.

Stipple Bio, Inc. · Form D, Apr 6, 2026
GV
Greg Verdine
Independent Director
TS
Thilo Schroeder
Managing Partner, Nextech and director
OH
Owen Hughes
Independent Director
DD
Derek DiRocco
Partner, RA Capital Management and director
Jeffrey Landau
Jeffrey Landau
Chief Executive Officer and director
Seranova Bio, Inc. · Form D, Feb 5, 2024
DS
Damien Soghoian
Executive officer and director
HT
Hui Tian
Director
SO
Sabah Oney
Director
LC
Leon Chen
Director

Sources

  1. SECStipple Bio, Inc. Form D, filed Apr 6, 2026
  2. SECSeranova Bio, Inc. Form D, filed Feb 5, 2024